Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-16726

Münz, C; Moormann, A (2008). Immune escape by Epstein-Barr virus associated malignancies. Seminars in Cancer Biology, 18(6):381-387.

[img]
Preview
PDF
1MB

View at publisher

Abstract

Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of virus carriers, despite the potent growth transforming potential of this virus. The increased frequency of EBV associated B cell lymphomas in immune compromised individuals suggests that tumor-free chronic infection with this virus is in part due to immune control. Here we discuss the evidence that loss of selective components of EBV specific immunity might contribute to EBV associated malignancies, like nasopharyngeal carcinoma, Burkitt's and Hodgkin's lymphoma, in otherwise immune competent patients. Furthermore, we discuss how current vaccine approaches against EBV might be able to target these selective deficiencies.

Citations

23 citations in Web of Science®
27 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

45 downloads since deposited on 11 Jan 2010
14 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Experimental Immunology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2008
Deposited On:11 Jan 2010 13:23
Last Modified:27 Nov 2013 21:30
Publisher:Elsevier
ISSN:1044-579X
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.1016/j.semcancer.2008.10.002
PubMed ID:18996483

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page